Prevalence and outcomes of atrial fibrillation in patients hospitalized with COVID-19.
Document Type
Article
Publication Date
9-1-2024
Publication Title
Current medical research and opinion
Abstract
OBJECTIVE: Atrial fibrillation (AF) is a common arrhythmia in patients at high cardiovascular risk. COVID-19 patients with underlying cardiovascular disease are at increased risk of poor clinical outcomes. In this study, we aimed to determine hospital outcomes among patients admitted with AF and COVID-19 infection.
METHODS: We conducted a retrospective analysis using the 2020 California State Inpatient data, including all COVID-19 hospitalizations of individuals aged ≥18. Primary outcomes were in-hospital mortality, prolonged length of stay (above the 75th percentile), vasopressor use, mechanical ventilation, and ICU admission. We compared adverse hospital outcomes between those with and without AF and used multivariable logistic regression to adjust for confounders.
RESULTS: This analysis included 94,114 COVID-19 hospitalizations, of which 9391 (10.0%) had AF. Patients with COVID-19 and AF had higher rates of adverse outcomes, including mortality (27.2% vs. 9.6%,
CONCLUSION: COVID-19 hospitalized patients frequently have underlying AF, which confers a higher risk of adverse hospital outcomes and mortality, even after adjusting for baseline comorbidities. Heightened awareness is needed in the treatment of hospitalized COVID-19 patients with AF.
Volume
40
Issue
9
First Page
1477
Last Page
1481
Recommended Citation
Vaidean GD, Rubens M, Ramamoorthy V, Saxena A, Appunni S, Khosla AA, Doke M, et al Prevalence and outcomes of atrial fibrillation in patients hospitalized with covid-19. Curr Med Res Opin. 2024 Sep;40(9):1477-1481. doi: 10.1080/03007995.2024.2378179. PMID: 39034775
DOI
10.1080/03007995.2024.2378179
ISSN
1473-4877
PubMed ID
39034775